Immunetrics, Lilly plan technology collaboration
8th Sep 2005, 13:31 GMT
Immunetrics, a computer simulation company whose technology assists the drug development process, will work with drug giant Eli Lilly and Co. to see how its modeling technology can be applied to designing clinical drug trials.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson